B BRAUN L5200 DEXTROSE INJECTIONS USP Dextrose Injections, 10%, 1000mL, EXCEL® Containers, 12/cs Max weekly quantity allowed: 10

• Model: L5200
• Volume / Container: 1,000 mL
• 12 Containers/ Case

EXCEL & PAB, the only PVC-free, DEHP-free containers with a full range of basic IV solutions. EXCEL & PAB eliminate the risk of plasticizer toxicity, reduces the risk of sub-therapeutic dosing and facilitate inspection of admixtures.

The B. Braun L5200 10% Dextrose Injection (1,000 mL, EXCEL® Container) provides a reliable, high‑volume intravenous carbohydrate solution suitable for patients requiring both hydration and a significant caloric substrate. The 10% dextrose concentration means each 100 mL delivers 10 g of dextrose, translating into a calorie rate of ~340 kcal per liter. This makes it a practical option for patients who cannot receive enteral nutrition or require supplemental carbohydrate support via IV. The large 1‑L bag supports extended infusion regimens, reducing the frequency of bag changes in active‑care settings such as intensive care or post‑operative units.

What distinguishes this product is its packaging and material design: the EXCEL® IV container is engineered to exclude PVC, DEHP and natural rubber latex in the fluid path, reducing potential risks of plasticizer exposure or latex-associated allergic reactions. Furthermore, its flexible bag configuration helps optimize storage, preparation and disposal in busy clinical settings. The absence of antimicrobial or bacteriostatic additives also means that, under aseptic technique, the solution can be used with medication additions or as part of compounding protocols. These design features make the product especially suitable for pediatric, neonatal, or sensitivity‑aware patient populations.

From an operational standpoint, this 10% dextrose solution aligns well with facility workflow and stocking needs. With 12 bags per case, pharmacies and supply departments can efficiently manage inventory and bulk procurement. The bag’s compatibility with standard infusion systems and the explicit labeling of NDC 0264‑7520‑00 (for the 1 L size) helps with regulatory tracking, billing and formulary integration. Because it offers a dual role—hydration plus caloric support—it can streamline IV fluid protocols and reduce the need for separate carbohydrate infusions in many cases. In sum, this product offers a strong balance of clinical utility, patient safety features and logistical convenience for institutions managing IV carbohydrate/hydration therapy.